Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

New Treatment for Tendinitis Being Tested

  • Broadcast in Health
Deborah Quilter

Deborah Quilter

×  

Follow This Show

If you liked this show, you should follow Deborah Quilter.
h:959053
s:10079357
archived

Tendinitis is one of the most common manifestations of repetitive strain injury, and anyone who has experienced it knows how debilitating it can be. They also know how quickly you can reinjure yourself and what it’s like to cope with a chronic case of tendinitis.

Today we are going to speak with Lee Buckler, who is the CEO of RepliCel Life Sciences, a Canadian-based company that is working on a product that will use your body’s own stem cells to heal tendon injuries. While the commercial product must meet government regulations and is still in the study stage, being able to have this treatment is still years away, I think you will find it quite fascinating to learn how this works – and why it could be such a boon to people with RSI.

 

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled